Metraipolis › archive › dc_c353bb87e626
Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA-Approved Oral Therapy — Europe PMC PMID:42698910
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42698910
- DOI
- 10.1002/hsr2.73178
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T03:06:57.834Z
- SHA-256 of the archived text
488a34a0cb533e974107f5c83db23cc51626cb65164ef79b91b7eefd53b885c4- Stable URL of this page
https://metraipolis.com/documento/dc_c353bb87e626
How to cite
Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA-Approved Oral Therapy — Europe PMC PMID:42698910 — Europe PMC (en), https://europepmc.org/article/MED/42698910 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c353bb87e626 (Metraipolis archive dc_c353bb87e626, sha256 488a34a0cb533e974107f5c83db23cc51626cb65164ef79b91b7eefd53b885c4)
BibTeX
@misc{dcc353bb87e626,
title = {Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA-Approved Oral Therapy — Europe PMC PMID:42698910},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42698910},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c353bb87e626; sha256 488a34a0cb533e974107f5c83db23cc51626cb65164ef79b91b7eefd53b885c4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42698910. Agents can read the archived copy with the MCP tool read_document.